An Investigation Into the Feasibility of Beetroot Juice Supplementation in People Living With Alzheimer's Disease.

Sponsor
University of the West of Scotland
Study ID
NCT07258004
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
65 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • Beetroot juice — DIETARY_SUPPLEMENT
    Participants will take a concentrated beetroot juice shot (70ml) twice daily for 1-week. Each shot contains 400mg of dietary nitrate (800mg per day).

Study Details

The goal of this clinical trial is to learn if taking a beetroot juice supplement will work in people living with Alzheimer's disease. The main questions it aims to answer are: * Can people living with Alzheimer's disease realistically drink beetroot juice regularly (for example, is it easy to take, free from side effects and acceptable)? * Does drinking beetroot juice twice a day improve health in people living with Alzheimer's disease? Researchers will look at how you managed with the beetroot juice, as well as if there were any improvements in your health measures. Participants will: * Complete testing before and after the intervention for no more than 3 hours each time * Complete a 1-day food diary before testing * Take a beetroot juice supplementation twice daily for 1-week * Keep a note of any problems with the beetroot juice

Key Dates

First listed
Dec 2, 2025
Start date
Mar 31, 2026
Status verified
Nov 2025
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Beetroot juice supplementation

Primary Outcome Measure

Feasibility of a beetroot juice intervention in people living with Alzheimer's disease [ Time Frame: From enrolment to the post-intervention testing 8-days later. ]

Central Contacts

Find similar trials

Related Studies